semaglutide 2.4 Efficacy and safety of once weekly 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial Wegovy (Semaglutide) Weight Loss Injector 2.4 mg/0.75 mL is a prescription medication that contains the active ingredient semaglutide Trial designs for SUSTAIN 2-4
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

























